Results 151 to 160 of about 9,615 (165)
Some of the next articles are maybe not open access.

Ibrutinib

Reactions Weekly, 2017
  +4 more sources

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2019
Jacqueline Barrientos   +2 more
exaly  

Cardiovascular Toxicities Associated With Ibrutinib

Journal of the American College of Cardiology, 2019
Javid J. Moslehi   +2 more
exaly  

Ibrutinib Regimens Versus Chemoimmunotherapy in Older Patients With Untreated CLL

New England Journal of Medicine, 2018
Kerry Rogers   +2 more
exaly  

Phase 3 Trial of Ibrutinib Plus Rituximab in Waldenström’s Macroglobulinemia

New England Journal of Medicine, 2018
Steven P. Treon   +2 more
exaly  

Ibrutinib and Venetoclax for First-Line Treatment of CLL

New England Journal of Medicine, 2019
Keyur P Patel   +2 more
exaly  

Ibrutinib Plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

New England Journal of Medicine, 2018
Sasanka M Handunnetti   +2 more
exaly  

Ibrutinib for the Treatment of Bing-Neel Syndrome: A Multicenter Study

Blood, 2019
Maria Lia Palomba   +2 more
exaly  

Home - About - Disclaimer - Privacy